Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD). The progressive decline in renal function, in fact, leads to the alteration of the metabolism of calcium (Ca), phosphorus (P) and vitamin D. Difference of other forms of hyperparathyroidism, renal SHPT has many pathogenetic peculiarities, which have been only in part clarified. Furthermore, in the long course of CKD, SHPT sometimes transforms into a hypercalcemic condition resembling the autonomous form of hyperparathyroidism (tertiary hyperparathyroidism; THP). The clinical consequences of SHPT in CKD patients are manifold, encompassing not only bone and mineral disorders, but also other metabolic and organic changes which frequently burden these patients. Although the medical therapeutic tools have substantially increased in number and improved in their efficacy in recent decades, we have as yet no demonstration of a clear benefit regarding the major clinical outcomes. Furthermore, some of these patients still require a surgical approach. Herein we discussed the clinical management and surgical treatment for a case of a recurrent secondary hyperparathyroidism.

Radioguided Parathyroidectomy for Recurrent Hyperparathyroidism : an effective multi-institutional approach at the University of Messina Hospital / A. Pino, M. Siracusa, G. Giacoppo, R.M. Ruggeri, G. Dionigi, S. Baldari, A. Campennì. - In: ATTI DELLA ACCADEMIA PELORITANA DEI PERICOLANTI, CLASSE DI SCIENCE MEDICO-BIOLOGICHE. - ISSN 0365-0294. - 109:1(2021), pp. 1-5. [10.6092/1828-6550/APMB.109.1.2021.CCS3]

Radioguided Parathyroidectomy for Recurrent Hyperparathyroidism : an effective multi-institutional approach at the University of Messina Hospital

G. Dionigi;
2021

Abstract

Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD). The progressive decline in renal function, in fact, leads to the alteration of the metabolism of calcium (Ca), phosphorus (P) and vitamin D. Difference of other forms of hyperparathyroidism, renal SHPT has many pathogenetic peculiarities, which have been only in part clarified. Furthermore, in the long course of CKD, SHPT sometimes transforms into a hypercalcemic condition resembling the autonomous form of hyperparathyroidism (tertiary hyperparathyroidism; THP). The clinical consequences of SHPT in CKD patients are manifold, encompassing not only bone and mineral disorders, but also other metabolic and organic changes which frequently burden these patients. Although the medical therapeutic tools have substantially increased in number and improved in their efficacy in recent decades, we have as yet no demonstration of a clear benefit regarding the major clinical outcomes. Furthermore, some of these patients still require a surgical approach. Herein we discussed the clinical management and surgical treatment for a case of a recurrent secondary hyperparathyroidism.
Endocrine surgery; parathyroid disease; hyperparathyroidism; CKD
Settore MED/18 - Chirurgia Generale
Article (author)
File in questo prodotto:
File Dimensione Formato  
3102-10732-1-SM.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 423.45 kB
Formato Adobe PDF
423.45 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/879329
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact